Risk of febrile convulsions after MMRV vaccination in comparison to MMR or MMR+V vaccination.
about
Assessing varicella vaccine effectiveness and its influencing factors using health insurance claims data, Germany, 2006 to 2015Risk of febrile seizures after first dose of measles-mumps-rubella-varicella vaccine: a population-based cohort study.Coverage, efficacy or dosing interval: which factor predominantly influences the impact of routine childhood vaccination for the prevention of varicella? A model-based study for Italy.Modelling Hospitalisation Ratios for Febrile Convulsions and Severe Varicella Under Combined Measles, Mumps, Rubella, and Varicella (MMRV-Priorix-Tetra™) Compared to Separate MMR + V Vaccination.Risk of Stroke after Herpes Zoster - Evidence from a German Self-Controlled Case-Series StudyImmunization in Canada: Update for 2015.A postmarket safety comparison of 2 vaccination strategies for measles, mumps, rubella and varicella in ItalyIssues in pediatric vaccine-preventable diseases in low- to middle-income countriesEvaluation of Combination Measles-Mumps-Rubella-Varicella Vaccine Introduction in Australia.Immunogenicity and reactogenicity of tetravalent vaccine for measles, mumps, rubella and varicella (MMRV) in healthy children: a meta-analysis of randomized controlled trials.[Pharmacovigilance in Germany : It is about time].Hospital admissions for seizure in Italy: a decennial retrospective analysis with a special focus on the burden in the pediatric age.Measles-mumps-rubella-varicella combination vaccine (ProQuad): a guide to its use in children in the E.U.[Benefits of large healthcare databases for drug risk research].Combination measles-mumps-rubella-varicella vaccination and the risk of febrile seizureThe Influence of Vaccine on Febrile Seizure.
P2860
Q33698107-5762EC30-5883-4BC9-974C-3757A21D4FD6Q33990235-D63CDBC4-7DA8-4B06-AB63-5DB949B0F6AAQ36171295-896621BA-43F5-45F2-B38F-0CC9CDF621DBQ36171675-9D529294-ECDF-4E84-BC94-BA621BCED18EQ36202708-BB23FAD5-2FEA-426C-8C05-1D53DA81BD93Q36728581-6F83B0E3-7965-40C7-94A3-989A8AC27F95Q37135247-5E9ECEF6-D92E-4CD5-BF86-E2270C92D127Q37264972-BB3B1215-3017-4E98-94D1-4369DDE3B147Q40094613-A73F5140-0029-4142-B3B3-C13D0B6F3896Q40151291-9F13C590-7DF8-4452-8255-E1F0A488641EQ40736061-83D7BB3F-FF22-48FE-9F58-01CB2C9FD6B4Q40995910-40B007E2-8FE5-403A-AFBE-6A5AACFDB930Q41318888-8181DFBA-34B3-4878-9EC4-20B8C6467F11Q41656205-4874EE5C-4E9D-4938-A1EA-E4725F7C77FEQ42763747-B952538D-55EE-4152-B8C6-D62D3F4C93EFQ52563841-533A51EE-EC1E-40CB-84A3-8602BC981F27
P2860
Risk of febrile convulsions after MMRV vaccination in comparison to MMR or MMR+V vaccination.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Risk of febrile convulsions af ...... n to MMR or MMR+V vaccination.
@en
Risk of febrile convulsions af ...... n to MMR or MMR+V vaccination.
@nl
type
label
Risk of febrile convulsions af ...... n to MMR or MMR+V vaccination.
@en
Risk of febrile convulsions af ...... n to MMR or MMR+V vaccination.
@nl
prefLabel
Risk of febrile convulsions af ...... n to MMR or MMR+V vaccination.
@en
Risk of febrile convulsions af ...... n to MMR or MMR+V vaccination.
@nl
P2093
P1433
P1476
Risk of febrile convulsions af ...... n to MMR or MMR+V vaccination.
@en
P2093
Edeltraut Garbe
Frank Kowalzik
Jakob Holstiege
P304
P356
10.1016/J.VACCINE.2013.12.011
P407
P50
P577
2013-12-25T00:00:00Z